SPC STOCKPILING PROVISION WOULD FURTHER DAMAGE EUROPEAN INNOVATION

January 28, 2019

Last week, the Legal Committee of the European Parliament voted in favour of the manufacturing export waiver for Supplementary Protection Certificates, with their judgement recommending that generic and biosimilar companies be allowed to build two-year stockpiles of medicines prior to SPC expiry.